Biofrontera Inc. short interest in 2024
In 2024, Biofrontera Inc.'s disclosed short interest ran from 2.05% of shares outstanding on 12 Jan 2024 to 3.77% on 31 Dec 2024, a change of +1.72 percentage points. The year's high was 8.86% on 29 Nov 2024 and its low 0.30% on 31 May 2024, averaging 2.94% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.11 days on 15 Jul 2024. Full history: Biofrontera Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025
2024 in figures
- Start of year
- 2.05% (12 Jan 2024)
- End of year
- 3.77% (31 Dec 2024)
- Change
- +1.72 pp
- High
- 8.86% (29 Nov 2024)
- Low
- 0.30% (31 May 2024)
- Average
- 2.94%
- Highest days to cover
- 1.11 (15 Jul 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 2.05% | 1.00 | results (8-K) |
| 31 Jan 2024 | 1.96% | 1.00 | |
| 15 Mar 2024 | 1.66% | 1.00 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 0.68% | 1.00 | |
| 15 Apr 2024 | 0.86% | 1.00 | |
| 30 Apr 2024 | 0.47% | 1.00 | |
| 31 May 2024 | 0.30% | 1.00 | 10-Q filed, results (8-K) |
| 14 Jun 2024 | 0.50% | 1.00 | |
| 28 Jun 2024 | 0.56% | 1.08 | |
| 15 Jul 2024 | 0.68% | 1.11 | |
| 31 Jul 2024 | 0.76% | 1.00 | |
| 15 Aug 2024 | 1.90% | 1.00 | 10-Q filed, results (8-K) |
| 13 Sep 2024 | 2.42% | 1.00 | |
| 30 Sep 2024 | 3.62% | 1.00 | |
| 15 Oct 2024 | 8.55% | 1.00 | |
| 31 Oct 2024 | 8.25% | 1.00 | |
| 15 Nov 2024 | 4.09% | 1.00 | results (8-K), 10-Q filed |
| 29 Nov 2024 | 8.86% | 1.00 | |
| 13 Dec 2024 | 6.85% | 1.00 | |
| 31 Dec 2024 | 3.77% | 1.02 |
See also: Biofrontera Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.